Acknowledging the theme of this issue, current RANZCOG clinical guidance that helps inform the topic of endometriosis include:

• Australian Living Evidence Guideline: Endometriosis

The Australian Living Evidence Guideline: Endometriosis, an update to the 2021 RANZCOG Endometriosis clinical practice guideline, was launched in May (2025). The Living Guideline supports the assessment and management of people with suspected or confirmed endometriosis or adenomyosis with evidence-based recommendations. Useful clinician and consumer resources have also been developed to accompany this important work. Further information about the Australian Living Evidence Guideline: Endometriosis can be found on pages 16 & 17.

Recent Research and Policy publications include updates to RANZCOG’s Birth After Caesarean Clinical Guideline (C-Obs 38) and Vasa Praevia Clinical Guideline (C-Obs 47).

The 2025 Birth After Caesarean Clinical Guideline (C-Obs 38) marks the fourth update to RANZCOG guidance on caring for people who have previously given birth by caesarean and are currently pregnant or planning another pregnancy. This is an important, and increasingly common, clinical scenario with caesarean birth rates continuing to rise in both Australia and Aotearoa New Zealand.

Version three of the Vasa Praevia Clinical Guideline (C-Obs 47) covers topics including:

• Screening, diagnosis and risk factors for vasa praevia
• Hospital admission versus outpatient management
• Timing of birth

The Research and Policy Team and Women’s Health Committee would like to thank all Guideline Development Group Chairs and members for their valued contributions.

Opportunities to contribute to guideline development and to provide feedback on draft documents are advertised in Connect. Please keep an eye out—and to access the full suite of our clinical guidance documents, please visit the RANZCOG website under the Resource Hub tab.